TY  - JOUR
AU  - Wright, David
AU  - Poon, Liona C
AU  - Rolnik, Daniel L
AU  - Syngelaki, Argyro
AU  - Delgado, Juan Luis
AU  - Vojtassakova, Denisa
AU  - de Alvarado, Mercedes
AU  - Kapeti, Evgenia
AU  - Rehal, Anoop
AU  - Pazos, Andrea
AU  - Carbone, Ilma Floriana
AU  - Dutemeyer, Vivien
AU  - Plasencia, Walter
AU  - Papantoniou, Nikos
AU  - Nicolaides, Kypros H
PY  - 2017
DO  - 10.1016/j.ajog.2017.08.110
UR  - http://hdl.handle.net/10668/11568
T2  - American journal of obstetrics and gynecology
AB  - The Aspirin for Evidence-Based Preeclampsia Prevention trial was a multicenter study in women with singleton pregnancies. Screening was carried out at 11-13 weeks' gestation with an algorithm that combines maternal factors and biomarkers (mean...
LA  - en
KW  - Aspirin for Evidence-Based Preeclampsia Prevention trial
KW  - aspirin
KW  - compliance
KW  - first-trimester screening
KW  - mean arterial blood pressure
KW  - placental growth factor
KW  - prediction
KW  - preeclampsia
KW  - pregnancy-associated plasma protein A
KW  - pyramid of pregnancy care
KW  - treatment effect
KW  - uterine artery Doppler
KW  - Adult
KW  - Aspirin
KW  - Double-Blind Method
KW  - Ethnicity
KW  - Evidence-Based Medicine
KW  - Female
KW  - Humans
KW  - Logistic Models
KW  - Maternal Age
KW  - Medication Adherence
KW  - Placenta Growth Factor
KW  - Platelet Aggregation Inhibitors
KW  - Pre-Eclampsia
KW  - Pregnancy
KW  - Pregnancy Trimester, First
KW  - Pregnancy-Associated Plasma Protein-A
KW  - Premature Birth
KW  - Pulsatile Flow
KW  - Randomized Controlled Trials as Topic
KW  - Risk Assessment
KW  - Risk Factors
KW  - Smoking
KW  - Treatment Outcome
KW  - Uterine Artery
KW  - Young Adult
TI  - Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia.
TY  - research article
VL  - 217
ER  -